Date:5/18/2010

0,000 shares authorized, none issued and outstanding) -- -- Common stock ($0.001 par value, 50,000,000 shares authorized, 16,790,851 and 16,714,267 issued and outstanding, respectively) 17 17 Additional paid-in capital 38,154 37,188 Accumulated other comprehensive income 5,900 5,879 Retained earnings 90,374 77,785 Total stockholders' equity 134,445 120,869 Total Liability and Shareholders' Equity $149,420 $140,363 China Sky One Medical, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows (Unaudited, $ in thousands) Three Months Ended March 31, 2010 2009 Cash flows from operating activities Net Income $12,589 $7,243 Adjustments to reconcile net cash provided by operating activities Depreciation and amortization 944 588 Change in fair value of derivative liability (4,927) -- Net change in assets and liabilities Accounts receivable 2,563 912 Inventories 190 (857) Prepaid expenses and other current assets (24) 36 Accounts payable and accrued expenses 1,143 736 Taxes payable 138 (165) Net cash provided by o
'/>"/>

SOURCE China Sky One Medical, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth